News

AgroSpheres and Wilbur-Ellis Launch FUN-THYME™, a Powerful Broad-Spectrum Biofungicide Built on Novel AgriCell® Technology

AgroSpheres, a biotechnology company transforming crop protection with biobased innovations, today announced the commercial launch of FUN-THYME™, a groundbreaking, broad-spectrum biofungicide derived from thyme oil and delivered through the company’s proprietary AgriCell encapsulation platform. Through an exclusive distribution agreement, Wilbur-Ellis will introduce FUN-THYME™ to growers across the United States, helping them protect high-value crops including almonds, apples, tomatoes, cherries, berries and grapes. This pioneering product offers a new level of pest management efficiency and a highly effective alternative to traditional chemistries for both conventional and organic farming systems.

The total U.S. fungicide market is estimated at over $33 billion annually, driven by demand for solutions that effectively manage resistant pathogens, improve yield and align with increasing regulatory pressures around pesticide residues.  This development and exclusive distribution partnership marks a significant step toward accelerating the adoption of sustainable agricultural solutions in the U.S. market.

FUN-THYME™

FUN-THYME™ is an advanced biofungicide that provides superior performance against a wide array of destructive fungal crop diseases while minimizing environmental impact. It harnesses potent biochemicals from thyme oil through a unique mode of action known as BM01 membrane disruption that is new to the Wilbur-Ellis portfolio. This mechanism reduces resistance and ensures safety for workers and the environment. Just one 2.5-gallon jug treats up to 20 acres, offering ultra-efficient application. Backed by three years of rigorous field development and a variety of trials, FUN-THYME™ delivers optimal product-market fit and strong grower returns.

FUN-THYME™ is the first commercial product to feature AgroSpheres’ novel AgriCell encapsulation technology, which stabilizes bioactive compounds against UV degradation, temperature changes and other volatile field stressors.  While bio-based compounds are typically unstable, AgriCell® protects them until they reach the target, attacking disease in multiple sites and stopping it at its source.  Free of solvents, microplastics and petrochemicals, AgriCell® is a fully biodegradable delivery system that naturally breaks down into nutrients beneficial to plant health.

 

Milestone and Partnership

“This is a major milestone for AgroSpheres,” said Payam Pourtaheri, CEO and Co-Founder of AgroSpheres. “FUN-THYME™ shows how we can harness the power of nature and deliver it with precision. With Wilbur-Ellis’ extensive distribution network and deep industry expertise, they are the ideal partner to bring this technology to growers looking to sustainably improve their crop yields.”

Ameer Shakeel, CTO and Co-Founder of AgroSpheres, highlighted the collaboration and innovation behind FUN-THYME™: “We couldn’t have asked for a better partner than Wilbur-Ellis. Our teams have worked together tirelessly to overcome the key challenges with bio-based formulations and promote long-term crop health.”

“This partnership aligns perfectly with our mission to bring innovative and sustainable solutions to our customers,” said Chris Wooley, Portfolio Manager for Specialty Actives at Wilbur-Ellis. “We’re excited to be the first to deliver AgriCell technology to the market and we see strong potential for this technology to serve as the foundation of a portfolio of next-generation biological products that meet the evolving needs of modern agriculture.”

Wooley added: “At Wilbur-Ellis, we’re committed to bringing breakthrough technologies like the AgriCell® to growers that maximize their productivity while adopting more sustainable practices. FUN-THYME™ is a unique solution that addresses both needs.”

At its launch, FUN-THYME™ is approved for use in Arizona, Florida, Michigan, North Carolina, New York, Oregon, Pennsylvania, Texas, Virginia, Washington and Wisconsin, with registration pending in California.

Read more here.

Recent News

10/22/2025

Virginia Catalyst Announces Round 19 of Grant Funding

The Virginia Catalyst announced today that it is accepting letters of intent (LOI) for Grant Round 19 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. “We at the Virginia Catalyst are pleased to provide funding in support of the Governor’s

10/21/2025

SRI multi-party team selected as an awardee by ARPA-H to develop at-home screening for ≥30 types of cancers

SRI, along with research partners Foothold Labs and Triple Ring Technologies and commercial partner Beacon Dx Health, has been awarded up to $34 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop technology as part of the POSEIDON (Platform Optimizing SynBio for Early Intervention and Detection in Oncology) program. This pioneering program

10/21/2025

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, QRX003, for the treatment of Netherton Syndrome. The designation follows previously granted Orphan